Soluble amyloid-beta

Biomarker

3 papers2 findings

  • Animals2

Interventions

1

Spermidine

downin reviews1

1 study
  1. Spermidine decreases soluble amyloid-beta.

    “Preclinical studies consistently show that spermidine enhances proteostasis, reduces soluble amyloid-beta”

    Reviewpreclinical models of aging and neurodegeneration

    Spermidine in the aging brain: mechanisms, preclinical evidence, and clinical perspectives

    Molecular biology reports21 Apr 2026

More on Spermidine

Upstream

1

APP

upin mice1

1 study
  1. APP increases soluble amyloid-beta in mice (33-fold).

    “soluble A beta levels in the brain were continually elevated, increasing 4-fold at 2 months and 33-fold in the APP23 Tg mice at 20 months of age when compared to the control mice.”

    Animalsin APP23 Tg mice compared to control micebrain

    The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease

    Molecular medicine (Cambridge, Mass.)1 Sep 2001

More on APP

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 03 in 12 months